These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 12084414

  • 1. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.
    Markianos M, Hatzimanolis J, Lykouras L, Christodoulou GN.
    Schizophr Res; 2002 Jul 01; 56(1-2):11-7. PubMed ID: 12084414
    [Abstract] [Full Text] [Related]

  • 2. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M, Hatzimanolis J, Lykouras L.
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun 01; 251(3):141-6. PubMed ID: 11697576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb 01; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 5. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S.
    Am J Psychiatry; 1998 Jul 01; 155(7):921-8. PubMed ID: 9659858
    [Abstract] [Full Text] [Related]

  • 6. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan 01; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 7. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 8. Dopamine receptor responsivity in schizophrenic patients in a drug-free state and after treatment with olanzapine.
    Lykouras L, Markianos M, Hatzimanolis J, Oulis P.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 25; 25(3):507-18. PubMed ID: 11370994
    [Abstract] [Full Text] [Related]

  • 9. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb 25; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 10. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2003 Feb 25; 160(2):290-6. PubMed ID: 12562575
    [Abstract] [Full Text] [Related]

  • 11. Elevation of prolactin levels by atypical antipsychotics.
    Turrone P, Kapur S, Seeman MV, Flint AJ.
    Am J Psychiatry; 2002 Jan 25; 159(1):133-5. PubMed ID: 11772702
    [Abstract] [Full Text] [Related]

  • 12. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb 25; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

  • 13. Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.
    Alfaro CL, Wudarsky M, Nicolson R, Gochman P, Sporn A, Lenane M, Rapoport JL.
    J Child Adolesc Psychopharmacol; 2002 Feb 25; 12(2):83-91. PubMed ID: 12188977
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H, Kuikka JT, Viinamäki H, Husso M, Tiihonen J.
    Psychiatry Clin Neurosci; 2009 Aug 25; 63(4):529-37. PubMed ID: 19496999
    [Abstract] [Full Text] [Related]

  • 15. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S.
    Am J Psychiatry; 2004 Sep 25; 161(9):1620-5. PubMed ID: 15337652
    [Abstract] [Full Text] [Related]

  • 16. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.
    Kapur S, Roy P, Daskalakis J, Remington G, Zipursky R.
    Am J Psychiatry; 2001 Feb 25; 158(2):311-4. PubMed ID: 11156818
    [Abstract] [Full Text] [Related]

  • 17. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.
    Volavka J, Czobor P, Cooper TB, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Lieberman JA.
    J Clin Psychiatry; 2004 Jan 25; 65(1):57-61. PubMed ID: 14744169
    [Abstract] [Full Text] [Related]

  • 18. Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients.
    Esel E, Basturk M, Saffet Gonul A, Kula M, Tayfun Turan M, Yabanoglu I, Sofuoglu S.
    Psychoneuroendocrinology; 2001 Aug 25; 26(6):641-7. PubMed ID: 11403983
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.
    Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA.
    Psychiatry Res; 1999 Nov 08; 92(1):33-44. PubMed ID: 10688158
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of olanzapine: an overview of pivotal clinical trials.
    Beasley CM, Tollefson GD, Tran PV.
    J Clin Psychiatry; 1997 Nov 08; 58 Suppl 10():7-12. PubMed ID: 9265910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.